Roche Holding | Umsatzkosten



Cost Of Sales Veränderung Datum
AbbVie USD 4.35B 344M 2025-06
Alcon AG USD 1.09B 27M 2025-03
Almirall EUR 195.09M 100.89M 2025-06
Amgen USD 3.01B 406M 2025-06
AstraZeneca USD 2.47B 232M 2025-06
Bayer EUR 4.36B 1.26B 2025-06
Biogen USD 605M 24.3M 2025-06
Bristol-Myers Squibb USD 3.37B 339M 2025-06
Eli Lilly USD 2.45B 223.6M 2025-06
Fresenius EUR 4.12B 117M 2025-06
Fresenius Medical Care EUR 3.58B 120M 2025-06
Galapagos EUR 4.71M 9.02M 2025-06
Genmab DKK 57M 15M 2025-06
Gilead Sciences USD 1.5B 39M 2025-06
GlaxoSmithKline GBP 2.16B 241M 2025-06
GRIFOLS EUR 1.15B 56.19M 2025-06
Hikma Pharmaceutical USD 895M 82M 2024-12
Lonza CHF 2.47B 532M 2024-12
Merck EUR 2.23B 93M 2025-06
Merck USD 2.82B 53M 2025-06
Novartis USD 3.32B 95M 2025-06
Orion EUR 168.1M 15.3M 2025-06
Pfizer USD 4.99B 2.4B 2025-06
Philips EUR 2.33B 79M 2025-06
Recordati EUR 220.03M 1.16M 2025-06
Regeneron Pharmaceuticals USD 530.2M 264.7M 2025-06
Roche Holding CHF 4.13B 393.5M 2024-12
Sanofi EUR 2.99B 103M 2025-06
UCB EUR 901M 50M 2024-12


Roche Holding Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.